Metraipolis › archive › dc_b6846659efbc
Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis — Europe PMC PMID:41011133
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41011133
- DOI
- 10.3390/ph18091261
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T09:38:39.802Z
- SHA-256 of the archived text
1c79264a0af13eacd91201dab67ce17406134ff6be8c089748e8c7bc635d1efe- Stable URL of this page
https://metraipolis.com/documento/dc_b6846659efbc
How to cite
Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis — Europe PMC PMID:41011133 — Europe PMC (en), https://europepmc.org/article/MED/41011133 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6846659efbc (Metraipolis archive dc_b6846659efbc, sha256 1c79264a0af13eacd91201dab67ce17406134ff6be8c089748e8c7bc635d1efe)
BibTeX
@misc{dcb6846659efbc,
title = {Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis — Europe PMC PMID:41011133},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41011133},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6846659efbc; sha256 1c79264a0af13eacd91201dab67ce17406134ff6be8c089748e8c7bc635d1efe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41011133. Agents can read the archived copy with the MCP tool read_document.